Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT
- PMID: 30200130
- PMCID: PMC6133449
- DOI: 10.1097/MD.0000000000012205
Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT
Abstract
To address the reliability of CT activity score (CTAS) and investigate the relationships between CTAS, lung function changes after treatment and the serum angiotensin-converting enzyme (SACE) levels.Fifty-seven sarcoidosis patients underwent chest high-resolution CT (HRCT) and spirometry, as well as SACE examination, were retrospectively analyzed. Follow-up spirometry in each patient was obtained about 6 months after the initial spirometry. The correlations between CTAS and pulmonary function changes were evaluated by Spearman correlation analysis. According to SACE status, patients were divided into normal and high level 2 subgroups. Comparisons of pulmonary function parameters, HRCT abnormalities extent scores between SACE normal and high 2 subgroups were performed with the Mann-Whitney U test or Independent samples t test.CTAS demonstrated significant correlations with lung function changes (Δ%VC: ρ= 0.543, P < .001; ΔFEV1.0/FVC:ρ = 0.417, P = .001; Δ%TLC: ρ = 0.309, P = .019). In addition, worse initial lung function, larger changes of lung function, and higher extent scores of HRCT were observed in SACE high-level subgroup.The findings of this study suggest that CTAS of initial HRCT is a promising index for disease activity in pulmonary sarcoidosis to some degree. Prospective studies with large cohort designed to address further verification are warranted before wide clinical practice.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures

Similar articles
-
Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay.J Comput Assist Tomogr. 1998 Mar-Apr;22(2):229-34. doi: 10.1097/00004728-199803000-00013. J Comput Assist Tomogr. 1998. PMID: 9530385
-
Sarcoidosis: correlation of HRCT findings with results of pulmonary function tests and serum angiotensin-converting enzyme assay.Kurume Med J. 1998;45(3):247-56. doi: 10.2739/kurumemedj.45.247. Kurume Med J. 1998. PMID: 9787595
-
Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 18;32(4):318-24. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 26847099
-
Serum angiotensin converting enzyme in sarcoidosis--its value in present clinical practice.Ann Clin Biochem. 1989 Jan;26 ( Pt 1):13-8. doi: 10.1177/000456328902600102. Ann Clin Biochem. 1989. PMID: 2544134 Review.
-
Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity.Am J Pharmacogenomics. 2003;3(4):233-43. doi: 10.2165/00129785-200303040-00002. Am J Pharmacogenomics. 2003. PMID: 12930157 Review.
Cited by
-
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.Dis Markers. 2019 Mar 3;2019:8565423. doi: 10.1155/2019/8565423. eCollection 2019. Dis Markers. 2019. PMID: 30944672 Free PMC article.
-
Lymphocyte Subsets and Pulmonary Nodules to Predict the Progression of Sarcoidosis.Biomedicines. 2023 May 13;11(5):1437. doi: 10.3390/biomedicines11051437. Biomedicines. 2023. PMID: 37239108 Free PMC article.
-
Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.Biomolecules. 2022 Sep 30;12(10):1400. doi: 10.3390/biom12101400. Biomolecules. 2022. PMID: 36291609 Free PMC article. Review.
-
Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.Front Immunol. 2021 Aug 11;12:719009. doi: 10.3389/fimmu.2021.719009. eCollection 2021. Front Immunol. 2021. PMID: 34456926 Free PMC article.
-
Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.BMC Pulm Med. 2020 Jun 1;20(1):155. doi: 10.1186/s12890-020-01191-x. BMC Pulm Med. 2020. PMID: 32487134 Free PMC article.
References
-
- Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007;28:36–52. - PubMed
-
- Sheffield EA. Pathology of sarcoidosis. Clin Chest Med 1997;18:741–54. - PubMed
-
- Wessendorf TE, Bonella F, Costabel U. Diagnosis of sarcoidosis. Clin Rev Allergy Immunol 2015;49:54–62. - PubMed
-
- Little BP. Sarcoidosis: overview of pulmonary manifestations and imaging. Semin Roentgenol 2015;50:52–64. - PubMed
-
- Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004;24:87–104. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous